Home / Health / Eli Lilly's Weight-Loss Drug Rivals Surgery
Eli Lilly's Weight-Loss Drug Rivals Surgery
24 May
Summary
- New drug shows over 30 percent body weight loss.
- Drug's effectiveness matches gastric bypass surgery.
- Medication could transform severe obesity treatment.
Eli Lilly has unveiled promising results for its new weight-loss drug. In recent trials, the highest dosage administered enabled participants to shed more than 30 percent of their body weight.
This remarkable efficacy level places the drug on par with the outcomes achieved through gastric bypass surgery. Such a development could revolutionize the management of severe obesity.
The pharmaceutical giant's new medication may also offer a potent additional therapy for various chronic diseases. The full impact of these findings is anticipated to unfold as further data becomes available.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
